Home/Create Medicines/Robert Hofmeister, PhD
RH

Robert Hofmeister, PhD

Chief Scientific Officer

Create Medicines

Create Medicines Pipeline

DrugIndicationPhase
MT-304Breast CancerPhase 1
CRT-401Epithelial TumorsPreclinical
CRT-402B-cell DepletionPreclinical
MT-303Frontline Hepatocellular Carcinoma (HCC)Phase 2
MT-302Frontline Gastroesophageal Junction (GEJ) CancerPhase 2